Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatmen...
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study
About this item
Full title
Author / Creator
Komori, Azusa , Otsu, Satoshi , Shimokawa, Mototsugu , Otsuka, Taiga , Koga, Futa , Ueda, Yujiro , Nakazawa, Junichi , Arima, Shiho , Fukahori, Masaru , Okabe, Yoshinobu , Makiyama, Akitaka , Taguchi, Hiroki , Honda, Takuya , Shibuki, Taro , Nio, Kenta , Ide, Yasushi , Ureshino, Norio , Mizuta, Toshihiko , Shirakawa, Tsuyoshi and Mitsugi, Kenji
Publisher
Singapore: Springer Nature Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Nature Singapore
Subjects
More information
Scope and Contents
Contents
Background
Patients with metastatic pancreatic cancer refractory to first-line chemotherapy (CTx) have few treatment options. It is unclear what kind of patients could be brought about survival benefit by 2nd-line CTx after refractory to gemcitabine + nab-PTX (GnP) or FOLFIRINOX.
Methods
This analysis was conducted as part of a multicenter...
Alternative Titles
Full title
Scoring model with serum albumin and CA19-9 for metastatic pancreatic cancer in second-line treatment: results from the NAPOLEON study
Authors, Artists and Contributors
Author / Creator
Otsu, Satoshi
Shimokawa, Mototsugu
Otsuka, Taiga
Koga, Futa
Ueda, Yujiro
Nakazawa, Junichi
Arima, Shiho
Fukahori, Masaru
Okabe, Yoshinobu
Makiyama, Akitaka
Taguchi, Hiroki
Honda, Takuya
Shibuki, Taro
Nio, Kenta
Ide, Yasushi
Ureshino, Norio
Mizuta, Toshihiko
Shirakawa, Tsuyoshi
Mitsugi, Kenji
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2816759084
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2816759084
Other Identifiers
ISSN
1341-9625
E-ISSN
1437-7772
DOI
10.1007/s10147-023-02354-6
